Trending Medical and health breaking news CDC Panel Recommends Pfizer COVID Boosters for Ages 12-15

Trending Medical and well being breaking information CDC Panel Recommends Pfizer COVID Boosters for Ages 12-15

Trending Medical and well being breaking information

This story was up to date at 9:32 a.m. Jan. 6, 2022. 

Jan. 5, 2022 – CDC Director Rochelle Walensky, MD, late Wednesday endorsed an advisory panel’s suggestion that 12- to 17-year-olds in the US ought to get the Pfizer COVID-19 booster shot a minimum of 5 months after a main sequence of vaccinations. 

Only a few hours earlier the company’s Advisory Committee on Immunization Practices voted 13-1 in favor of the advice.

The CDC had already mentioned 16- and 17-year-olds “might” obtain a Pfizer booster however right this moment’s suggestion provides the 12-15 group and strengthens the “might” to “ought to” for 16- and 17-year-olds.

The vote comes after the FDA on Monday licensed the Pfizer vaccine booster dose for 12- to 15-year-olds.

The FDA motion up to date the authorization for the Pfizer vaccine, and the company additionally shortened the really useful time between a second dose and the booster to five months or extra (from 6 months). A 3rd main sequence dose can also be now licensed for sure immunocompromised kids between 5 and 11 years previous. Full particulars can be found in an FDA information launch.

The CDC on Tuesday additionally backed the shortened time-frame and a 3rd main sequence dose for some immunocompromised kids 5 to 11 years previous. However the CDC delayed a choice on a booster for 12- to 15-year-olds till it heard from its Advisory Committee on Immunization Practices right this moment.

The choice got here as college districts nationwide are wrestling with selections of whether or not to maintain faculties open or revert to a digital format as circumstances surge, and as pediatric COVID-19 circumstances and hospitalizations attain new highs.

The one dissenting vote got here from Helen Keipp Talbot, MD, affiliate professor of drugs at Vanderbilt College in Nashville.

She mentioned after the vote, “I’m simply high quality with children getting a booster. This isn’t me in opposition to all boosters. I simply actually need the U.S. to maneuver ahead with all children.”

Talbot mentioned earlier within the remark interval, “If we divert our public well being from the unvaccinated to the vaccinated, we’re not going to make a big effect. Boosters are extremely essential however they received’t remedy this downside of the crowded hospitals.”

She mentioned vaccinating the unvaccinated should be the precedence.

“In case you are a mum or dad on the market who has not but vaccinated your youngster as a result of you may have questions, please, please speak to a well being care supplier,” she mentioned.

Among the many 13 supporters of the advice was Oliver Brooks, MD, chief medical officer of Watts HealthCare Company in Los Angeles.

Brooks mentioned extending the inhabitants for boosters is one other instrument within the toolbox.

“If it’s a hammer, we must always hit that nail exhausting,” he mentioned.

Sara Oliver, MD, ACIP’s lead for the COVID-19 work group, introduced the case behind the advice.

She famous the hovering Omicron circumstances.

“As of Jan. 3, the 7-day common had reached an all-time excessive of practically 500,000 circumstances,” Oliver famous.

Since this summer time, she mentioned, adolescents have had a better fee of incidence than adults.

“Nearly all of COVID circumstances proceed to happen among the many unvaccinated,” she mentioned, “with unvaccinated 12- to 17-year-olds having a 7-times-higher threat of testing constructive for SARS-Cov-2 in comparison with vaccinated 12- to 17-year-olds. Unvaccinated 12- to 17-year-olds have round 11 instances increased threat of hospitalization than vaccinated 12- to 17-year-olds.”

“Vaccine effectiveness in adolescents 12- to 15-years-old stays excessive,” Oliver mentioned, however proof exhibits, there could also be “some waning over time.”

Dialogue of threat centered on myocarditis.

Oliver mentioned myocarditis charges reported after the Pfizer vaccine in Israel throughout all populations as of Dec. 15 present that “the charges of myocarditis after a 3rd dose are decrease than what’s seen after the second dose.”

Learn Extra

Leave a Comment

Your email address will not be published. Required fields are marked *